SCHEMBL4841196

SCHEMBL4841196

CCN(CC)C(=O)c1cc(F)c(Cl)nc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.57
NFE2L2 Q16236 1/20 0.57
ALPL P05186 2/20 0.45
ALDH1A1 P00352 2/20 0.42
MAPT P10636 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HSP90AA1 P07900 3/20 0.40
HSP90AB1 P08238 3/20 0.40
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39
COMT P21964 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TSHR P16473 2/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2920688 0.81 KEAP1 (0.62) KEAP1NFE2L2ALPLALDH1A1MAPT
SCHEMBL18149209 0.79 KEAP1 (0.59) KEAP1NFE2L2ALPLALDH1A1POLB
SCHEMBL12773832 0.77 KEAP1 (0.53) KEAP1NFE2L2ALPLMAPTPOLB
SCHEMBL20788869 0.77 KEAP1 (0.66) KEAP1NFE2L2MAPTL3MBTL1HPGD
SCHEMBL14395311 0.76 KEAP1 (0.56) KEAP1NFE2L2ALPLRAB9A
SCHEMBL10518552 0.75 KEAP1 (0.69) KEAP1NFE2L2ALDH1A1SMN1; SMN2POLB
SCHEMBL860929 0.74 KEAP1 (0.57) KEAP1NFE2L2ALDH1A1HPGDSMN1; SMN2
SCHEMBL1189483 0.73 ALDH1A1 (0.44) ALPLALDH1A1MAPTL3MBTL1HSP90AA1
SCHEMBL919984 0.73 KEAP1 (0.71) KEAP1NFE2L2ALDH1A1MAPTHPGD
SCHEMBL113812 0.73 KEAP1 (1.00) KEAP1NFE2L2ALPLALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414136-B2 Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt ASAHI GLASS COMPANY, LIMITED (JP) 2008-08-19 US claimed
US-7414136-B2 Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt ASAHI GLASS COMPANY, LIMITED (JP) 2008-08-19 US disclosed
US-20060058529-A1 Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt ASAHI GLASS COMPANY, LIMITED (JP) 2006-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058529-A1 Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt ARL1, CBR3, ZC3HAV1L KEAP1 1598/4885NFE2L2 2800/4885ALPL 934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.